Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Platelet phenotype changes associated with breast cancer and its treatment.

Platelets - 1 Nov 2016

Holmes Chris E, Levis Jamie E, Schneider David J, Bambace Nadia M, Sharma Deva, Lal Inder, Wood Marie E, Muss Hyman B

Abstract excerpt

Platelets and their granular contents influence both angiogenesis and breast cancer progression. This study was performed to assess the effect of breast cancer and its treatment on platelet biology and the response to inhibition of the platelet P2Y12 receptor. Receptor-specific platelet activation and inhibition was studied for three platelet-associated proteins important in cancer angiogenesis and progression,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Platelets
Share to Flow Cytometry
Share to Platelet Activation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Platelet Aggregation Inhibitors

Share to Purinergic P2Y Receptor Antagonists

Share to Receptors, Purinergic P2Y12

Share to Transforming Growth Factor beta1

Share to Vascular Endothelial Growth Factor A

Source

Identifiers

PMID: 27135253
DOI: 10.3109/09537104.2016.1171302

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Platelet phenotype changes associated with breast cancer and its treatment.PMID 27135253Read ↗

Proteomic and functional profiling of platelet-derived extracellular vesicles released under physiological or tumor-associated conditionsSemantic proximity Read ↗

EP4 as a Therapeutic Target for Aggressive Human Breast CancerSemantic proximity Read ↗

Tumor-Educated-Platelets interact with Breast Cancer-Stem-Cells via P-selectin- PSGL1 and ensure stemness and metastasis through WNT-β-Catenin-VEGF-VEGFR2 intra-cellular signaling: Therapeutic modulation by aspirinSemantic proximity Read ↗

Platelets disrupt vasculogenic mimicry by cancer cellsSemantic proximity Read ↗

Molecular basis for activation and biased signaling at the thrombin-activated GPCR proteinase activated receptor-4 (PAR4).Semantic proximity Read ↗

LMWHs and DOACs Modulate Cancer Cell Procoagulant Activity and Viability: Comparison with QuercetinSemantic proximity Read ↗

Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC).Semantic proximity Read ↗

Estrogen, inflammation, and platelet phenotype.Semantic proximity Read ↗

Platelet PI3Kβ regulates breast cancer metastasisSemantic proximity Read ↗

Analysis of the potential of cancer cell lines to release tissue factor-containing microvesicles: correlation with tissue factor and PAR2 expressionSemantic proximity Read ↗

Platelet response to a small molecule inhibitor of α2β1 integrin is associated with ITGA2 C807T dimorphism.Semantic proximity Read ↗

Biology and Pharmacology of the Platelet P2Y12 ReceptorSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.